Observatory · observe first

Follow the allocation change

Matched S&P 500 members → sector → industry → sub-industry → company. Each step uses the same percentage points.

Historical time machine
Historical observation
20182026
Universe›Health Care›Pharmaceuticals›Pharmaceuticals
Pharmaceuticals · weight
4.11%
Industry change · 12M
+0.25 pp
Pharmaceuticals · contribution
+0.248 pp
Company participation
86%
of industry constituents above their 6M weight average

4 · Companies driving this sub-industry

Nov 2025 · sorted by absolute contribution to 12-month change

CompanyCountryMarket capUniverse weight3M contribution12M contribution12M price returnAbove 6M weight average
Lilly (Eli) →
LLY
United States$1016.7bn1.997%+0.560 pp+0.331 pp+36.2%Yes
Johnson & Johnson →
JNJ
United States$498.5bn0.979%+0.095 pp+0.156 pp+37.6%Yes
Bristol Myers Squibb →
BMY
United States$100.2bn0.197%-0.002 pp-0.068 pp-12.8%Yes
Zoetis →
ZTS
United States$56.5bn0.111%-0.033 pp-0.064 pp-25.9%No
Merck & Co. →
MRK
United States$260.2bn0.511%+0.076 pp-0.056 pp+7.0%Yes
Pfizer →
PFE
United States$146.3bn0.287%-0.004 pp-0.040 pp+5.3%Yes
Viatris →
VTRS
United States$12.3bn0.024%-0.001 pp-0.010 pp-14.2%Yes

Company contributions use weights among matched S&P 500 members and add through each level without rescaling. Companies without matched shares and prices are omitted. These observations do not establish official index weights or actual fund flows.